Abstract Details
|
Faranak Ebrahimian Saadabad
PRESENTER |
Mr. Ebrahimian Saadabad has nothing to disclose. |
| Salih Cayir | Mr. Cayir has nothing to disclose. |
| Yanghong Yang, MD | Dr. Yang has nothing to disclose. |
| Tommaso Volpi | Tommaso Volpi has nothing to disclose. |
| Takuya Toyonaga | No disclosure on file |
| Jean-Dominique Gallezot | The institution of Jean-Dominique Gallezot has received research support from Intra-cellular Therapies, Inc.. The institution of an immediate family member of Jean-Dominique Gallezot has received research support from Cerevel. |
| Adam Mecca (Yale School of Medicine) | Adam Mecca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Adam Mecca has received research support from NIH. The institution of Adam Mecca has received research support from Eli Lilly. The institution of Adam Mecca has received research support from Genetech. The institution of Adam Mecca has received research support from Janssen. |
| Arman Fesharaki-Zadeh, MD, PhD (Yale University) | Dr. Fesharaki-Zadeh has nothing to disclose. |
| David Matuskey, MD (Yale University) | Dr. Matuskey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Eleisver. The institution of Dr. Matuskey has received research support from Abbvie. |